The NIH gave funding eligibility to 13 lines of human embryonic stem cells, including four widely used lines obtained by University of Wisconsin scientists. "Many people who had been working on these lines, and concerned about whether they would be able to continue to work with these lines, will now be reassured that their research can now go forward," said Francis Collins, the agency's director.

Related Summaries